Varices in Early Histological Stage Primary Biliary Cirrhosis

被引:50
作者
Ali, Ahmad H. [1 ]
Sinakos, Emmanouil [1 ]
Silveira, Marina G. [1 ]
Jorgensen, Roberta A. [1 ]
Angulo, Paul [1 ]
Lindor, Keith D. [1 ]
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
关键词
portal hypertension; esophageal varices; screening; esophagogastroduodenoscopy; predictive models; URSODEOXYCHOLIC ACID DELAYS; ESOPHAGEAL-VARICES; CONTROLLED-TRIAL; DOUBLE-BLIND; DESTRUCTIVE CHOLANGITIS; PORTAL-HYPERTENSION; HYPERPLASIA; MULTICENTER; PROGRESSION; FEATURES;
D O I
10.1097/MCG.0b013e3181f18c4e
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Background/Goals: Esophageal varices (EV) in early histological stages of primary biliary cirrhosis (PBC) have been recognized but not well defined. We sought to determine the prevalence, clinical characteristics, and predictors of EV in early-stage PBC, as well as to evaluate the effectiveness of recent guidelines regarding EV screening in PBC patients. Study: We retrospectively reviewed the charts of 325 PBC patients who had undergone complete evaluation before enrollment into 2 large clinical trials at the Mayo Clinic. Results: Nineteen percent (62/325) of our patient population had EV on esophagogastroduodenoscopy; 6% (8/127) of early-stage PBC patients had EV. Ninety five percent of our PBC patients with varices met at least one of the following conditions: male sex, low albumin (< 3.5 g/dL), elevated bilirubin level (>= 1.2 mg/dL), and/or prolonged prothrombin time (>= 12.9 s). The sensitivity and specificity of these variables in combination to predict the presence of varices were 95% and 55%, respectively. Serum bilirubin >= 1.2 mg/dL and albumin < 3.5 were independent predictors of varices with hazard values of 5.4 and 3.5 respectively. Conclusions: EV can occur in a minority of early-stage PBC patients. Various models may be used to identify PBC patients who are candidates for screening esophagogastroduodenoscopy for EV. Based on adequate performance and its simplicity, we propose that male sex, low albumin, elevated bilirubin, and/or prolonged prothrombin time be used as a model to noninvasively predict EV. Further validation is required.
引用
收藏
页码:E66 / E71
页数:6
相关论文
共 26 条
[21]
PORTAL-HYPERTENSION IN PRIMARY BILIARY-CIRRHOSIS - RELATIONSHIP WITH HISTOLOGICAL FEATURES [J].
NAVASA, M ;
PARES, A ;
BRUGUERA, M ;
CABALLERIA, J ;
BOSCH, J ;
RODES, J .
JOURNAL OF HEPATOLOGY, 1987, 5 (03) :292-298
[22]
Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis:: results of a double-blind controlled multicentric trial [J].
Parés, A ;
Caballería, L ;
Rodés, J ;
Bruguera, M ;
Rodrigo, L ;
García-Plaza, A ;
Berenguer, J ;
Rodríguez-Martínez, D ;
Mercader, J ;
Velicia, R .
JOURNAL OF HEPATOLOGY, 2000, 32 (04) :561-566
[23]
Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis [J].
Poupon, RE ;
Lindor, KD ;
CauchDudek, K ;
Dickson, ER ;
Poupon, R ;
Heathcote, EJ .
GASTROENTEROLOGY, 1997, 113 (03) :884-890
[24]
A MULTICENTER, CONTROLLED TRIAL OF URSODIOL FOR THE TREATMENT OF PRIMARY BILIARY-CIRRHOSIS [J].
POUPON, RE ;
BALKAU, B ;
ESCHWEGE, E ;
POUPON, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (22) :1548-1554
[25]
RUBIN E, 1965, AM J PATHOL, V46, P387
[26]
ZEEGEN R, 1969, LANCET, V2, P9